SEC 13F Intelligence

THESEUS PHARMACEUTICALS INC

CUSIP 88369M101

Theseus Pharmaceuticals Inc has 39 institutional holders in Filings Flow’s 13F database, together reporting 28.79M shares worth $135M as of Q4 2022.

Institutional Holders
39
Q4 2022
Reported Value
$135M
Ticker
unmapped
private placement or foreign
Quarters Tracked
2

Ownership Trend

Institutional holders
Q4 ’21: 34Q4 ’21Q4 ’22: 39Q4 ’22filingsflow.com
Total reported value
Q4 ’21: $333MQ4 ’21Q4 ’22: $135MQ4 ’22filingsflow.com

Holders

Manager% of PortfolioValueSharesQuarter
Legal & General Group Plc$432.4B AUM0.00%$7,8171.9KQ1 2025

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.